Omada Health, Inc.
OMDA
$12.61
$0.040.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.85M | 68.03M | 61.37M | 54.96M | 47.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.85M | 68.03M | 61.37M | 54.96M | 47.98M |
| Cost of Revenue | 22.18M | 22.96M | 21.07M | 23.06M | 15.85M |
| Gross Profit | 53.66M | 45.07M | 40.31M | 31.90M | 32.13M |
| SG&A Expenses | 38.83M | 37.28M | 34.63M | 31.49M | 30.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.57M | 70.54M | 65.72M | 63.36M | 55.08M |
| Operating Income | 3.28M | -2.51M | -4.34M | -8.40M | -7.10M |
| Income Before Tax | 5.16M | -3.18M | -5.31M | -9.45M | -8.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.16M | -3.18M | -5.31M | -9.45M | -8.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.16M | -3.18M | -5.31M | -9.45M | -8.25M |
| EBIT | 3.28M | -2.51M | -4.34M | -8.40M | -7.10M |
| EBITDA | 4.73M | -1.15M | -2.99M | -7.06M | -5.82M |
| EPS Basic | 0.09 | -0.06 | -0.24 | -1.15 | -1.04 |
| Normalized Basic EPS | 0.06 | -0.01 | -0.15 | -0.72 | -0.65 |
| EPS Diluted | 0.08 | -0.06 | -0.24 | -1.15 | -1.04 |
| Normalized Diluted EPS | 0.05 | -0.01 | -0.15 | -0.72 | -0.65 |
| Average Basic Shares Outstanding | 58.06M | 57.66M | 21.97M | 8.24M | 7.95M |
| Average Diluted Shares Outstanding | 63.93M | 57.66M | 21.97M | 8.24M | 7.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |